Skip to main content
SpringerLink
Log in

News from the 42nd European Symposium on Clinical Pharmacy, 16–18 October 2013, Prague

  • Practical Issues and Updates
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

‘Implementation of Clinical Pharmacy Practice: Research, Education and Management’ was the title of the 42nd European Society of Clinical Pharmacy (ESCP) Symposium on Clinical Pharmacy, held on 16–18 October 2013 in Prague. The symposium was attended by >500 participants, featured numerous lectures and workshops, and included the presentation of >250 posters and oral communications. This report highlights information from selected plenary lectures that discussed methods of implementing clinical pharmacy with the aim of achieving high-quality clinical practice and, ultimately, the best health for the individual.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Carter BL. The implementation of clinical pharmacy practice in the USA [opening plenary lecture]. In: 42nd European Symposium on Clinical Pharmacy, 16–18 Oct 2013, Prague.

  2. Spinewine A. Implementation of clinical pharmacy in the hospital setting in Europe: different models of care, successes and failures, future recommendations [plenary lecture 1.1]. In: 42nd European Symposium on Clinical Pharmacy, 16–18 Oct 2013, Prague.

  3. Chen T. Implementation of clinical pharmacy in Australia: models of care, home medicines reviews, primary care medical home model [plenary lecture 1.2]. In: 42nd European Symposium on Clinical Pharmacy, 16–18 Oct 2013, Prague.

  4. Carter BL, Bergus GR, Dawson JD, et al. A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J Clin Hypertens (Greenwich). 2008;10(4):260–71.

    Article  Google Scholar 

  5. Frontini R, Miharija-Gala T, Sykora J. EAHP Survey 2010 on hospital pharmacy in Europe: parts 4 and 5. Clinical services and patient safety. Eur J Hosp Pharm. 2013;20:69–73.

    Google Scholar 

  6. Frontini R, Miharija-Gala T, Sykora J. EAHP Survey 2010 on hospital pharmacy in Europe: part 1. General frame and staffing. Eur J Hosp Pharm. 2012;19:385–7.

    Google Scholar 

  7. Spinewine A, Fialová D, Bryne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging. 2012;29(6):495–510.

    Article  PubMed  Google Scholar 

  8. Castelino RL, Bajorek BV, Chen TF. Are interventions recommended by pharmacists during Home Medicines Review evidence-based? J Eval Clin Pract. 2011;17(1):104–10.

    Article  PubMed  Google Scholar 

  9. Castelino RL, Hilmer SN, Bajorek BV, et al. Drug Burden Index and potentially inappropriate medications in community-dwelling older people: the impact of Home Medicines Review. Drugs Aging. 2010;27(2):135–48.

    Article  PubMed  Google Scholar 

  10. Nishtala PS, Hilmer SN, McLachlan AJ, et al. Impact of residential medication management reviews on drug burden index in aged-care homes: a retrospective analysis. Drugs Aging. 2009;26(8):677–86.

    Article  PubMed  Google Scholar 

  11. Castelino RL, Bajorek BV, Chen TF. Retrospective evaluation of home medicines review by pharmacists in older Australian patients using the medication appropriateness index. Ann Pharmacother. 2010;44(12):1922–9.

    Article  PubMed  Google Scholar 

  12. Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167(8):781–7.

    Article  PubMed  Google Scholar 

  13. Kardas P. Non-adherence to medication in Central Europe: a call for action. Variations across populations, settings and countries, effective assessment methods and interventions, coopoeration of clinical pharmacists and general practitioners [plenary lecture 2.1]. In: 42nd European Symposium on Clinical Pharmacy, 16–18 Oct 2013, Prague.

  14. van den Bemt B. Medication adherence: impact of practical and psychological factors [plenary lecture 2.2]. In: 42nd European Symposium on Clinical Pharmacy, 16–18 Oct 2013, Prague.

  15. Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15.

    Article  PubMed  Google Scholar 

  16. Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705.

    Article  PubMed  Google Scholar 

  17. Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Demonceau J, Ruppar T, Kirstanto P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs. 2013;73(6):545–62.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Vervloet M, Linn AJ, van Weert JC, et al. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc. 2012;19(5):696–704.

    Article  PubMed Central  PubMed  Google Scholar 

  20. White S, Clyne W, Mshelia C. An educational framework for managing and supporting medication adherence in Europe. Pharm Educ. 2013;31(1):118–20.

    Google Scholar 

  21. Bates I. Pregraduate education in clinical pharmacy in Europe: recent situation, experiences and future directions [plenary lecture 3.1]. In: 42nd European Symposium on Clinical Pharmacy, 16–18 Oct 2013, Prague.

  22. Kinnear M. Postgraduate education in clinical pharmacy in Europe [plenary lecture 3.2]. In: 42nd European Symposium on Clinical Pharmacy, 16–18 Oct 2013, Prague.

  23. Leendertse A. The role of translational research in the implementation of clinical pharmacy practice in Europe [plenary lecture 3.3]. In: 42nd European Symposium on Clinical Pharmacy, 16–18 Oct 2013, Prague.

  24. Lampert M. Management of clinical pharmacy services: how best to allocate healthcare resources [plenary lecture 3.4]. In: 42nd European Symposium on Clinical Pharmacy, 16–18 Oct 2013, Prague.

  25. Kaufmann CP, Tremp R, Hersberger KE, et al. Inappropriate prescribing: a systematic overview of published assessment tools. Eur J Clin Pharmacol (Epub 10 Sep 2013).

  26. Langerova P, Vrtal J, Urbánek K. Adverse drug reactions as cause of hospital admissions in childhoold [abstract no. PT07]. In: 42nd European Symposium on Clinical Pharmacy, 16–18 Oct 2013, Prague.

  27. Weil T, Angoulvant F, Boulkedid R, et al. POPI: a tool to identify inappropriate prescribing in pediatrics: consensus validation [abstract no. HP-PC17]. In: 42nd European Symposium on Clinical Pharmacy, 16–18 Oct 2013, Prague.

Download references

Disclosure

The preparation of this article was not supported by any external funding.

Author information

Authors and Affiliations

  1. Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand

    Katherine A. Lyseng-Williamson

Authors
  1. Katherine A. Lyseng-Williamson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Katherine A. Lyseng-Williamson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lyseng-Williamson, K.A. News from the 42nd European Symposium on Clinical Pharmacy, 16–18 October 2013, Prague. Drugs Ther Perspect 30, 26–32 (2014). https://doi.org/10.1007/s40267-013-0090-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40267-013-0090-4

Keywords

Search

Navigation